Semaglutide Pen Injector trials for Obesity

All Semaglutide Pen Injector trials · All Obesity trials

Phase breakdown

Recruiting trials studying Semaglutide Pen Injector for Obesity

• Feasibility of Semaglutide in Advanced Lung Disease
  NCT05746039 · Phase: Phase 1, Phase 2 · Ages: 18 Years to 80 Years · Sex: All (male and female) · 1 location
• JOULE - Metabolic Adaptation to Weight Loss in Response to a Behavioural Lifestyle Program With or Without Semaglutide in Adolescents With Obesity
  NCT06852391 · Phase: Phase 4 · Ages: 12 Years to 17 Years · Sex: All (male and female) · 1 location
• Obesity Complicating Type 1 Diabetes: GLP-1 Analogue Anti-obesity Treatment
  NCT06411210 · Phase: Phase 2 · Ages: 18 Years to 30 Years · Sex: All (male and female) · 1 location

Common questions

How many trials study Semaglutide Pen Injector for Obesity?

3 recruiting trials.

Is this list complete?

No. For the full record, search ClinicalTrials.gov.